---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-286206"
form_type: "8-K"
ticker: "OLMA"
cik: "0001750284"
company_name: "Olema Pharmaceuticals, Inc."
filed_at: "2025-11-18T23:59:59+00:00"
generated_at: "2026-05-16T18:50:21.518550+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Olema terminates ATM prospectus; no further sales until new filing

## Summary
- Terminated ATM prospectus effective November 18, 2025.
- Sales Agreement with TD Securities dated January 6, 2025 remains in force.
- No further sales of common stock under the ATM until new prospectus filed.
- Olema had not disclosed any sales under the prior ATM; no amounts given.
- Move may indicate intent to file updated prospectus or reduce equity dilution.

## SEC filing metadata
- accession: 0001193125-25-286206
- form_type: 8-K
- ticker: OLMA
- cik: 0001750284
- company_name: Olema Pharmaceuticals, Inc.
- filed_at: 2025-11-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750284/000119312525286206/0001193125-25-286206-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750284/000119312525286206/d86905d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-286206
- JSON: https://secwatch.observer/filing/0001193125-25-286206.json
- Plain text: https://secwatch.observer/filing/0001193125-25-286206.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.